I’ve avoided this topic for good reason but with the recent surge in COVID-19 cases it seemed like a good time to talk about our old friend fluvoxamine. Coronavirus (COVID-19) may lead to serious illness as result of an excessive immune response termed a cytokine storm. An older antidepressant medication called Fluvoxamine may help prevent clinical deterioration of patients by stimulating sigma-1 receptors which regulate cytokine production.
Timestamps:
COVID19 and cytokines 0:39
Study presentation 02:34
Mechanism of action 05:12
Conclusion 06:28
Find additional content see our other social media accounts:
[ Ссылка ]
Facebook: @ShrinksInSneakers
Twitter: @AndPsychiatry
Instagram: @Shrinks_In_Sneakers
Disclaimer: This is not medical advice, and the information is provided for educational purposes only. Please consult your doctor for any specific medical questions.
All content is created for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider. If you think you have a medical emergency, call your doctor, go to the emergency department, or call 911. We do not endorse any specific treatment, tests, or procedures. Reliance on this information is solely at your own risk.
